Sageworth Trust’s Quest Diagnostics DGX Stock Holding History

Sageworth Trust’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3	Closed	–	–	223
2020 Q2	$0	Buy	+3	New	+$318	﹤0.01%	243
2018 Q2	–	Sell	-106	Closed	-$11K	–	157
2018 Q1	$11K	Buy	+106	New	+$10.9K	﹤0.01%	85

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Sageworth Trust's DGX Position: Q3 2020 in Review

Sageworth Trust sold out of Quest Diagnostics (DGX) in Q3 2020, closing a stake of 3 shares.

Sageworth Trust first reported a position in DGX in Q1 2018 and held it in 2 quarters. The position peaked at $11K in Q1 2018. 757 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

Sageworth Trust reported no remaining Quest Diagnostics position as of Q3 2020 after selling out during the quarter.
Sageworth Trust sold 3 Quest Diagnostics shares in Q3 2020.
Sageworth Trust first reported a position in Quest Diagnostics in Q1 2018 and held it in 2 quarters.
Sageworth Trust's Quest Diagnostics position peaked at $11K in Q1 2018.
757 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on Sageworth Trust's 13F filing for Q3 2020, filed 4 Nov 2020.